WOONSOCKET, R.I., May 10, 2017 /PRNewswire/ -- Shareholders of
CVS Health (NYSE: CVS) re-elected all eleven standing members of
the CVS Health Board of Directors and voted to elect the Honorable
Mary L. Schapiro, the 29th chairman of the U.S. Securities and
Exchange Commission (SEC), as a new member of the company's Board
today during the company's Annual Meeting of Stockholders.
The standing CVS Health directors who were re-elected to the
Board include: Richard M. Bracken;
C. David Brown II; Alecia A. DeCoudreaux; David W. Dorman (Chairman); Nancy-Ann M. DeParle; Anne M. Finucane; Larry
J. Merlo; Jean-Pierre Millon;
Richard J. Swift; William G. Weldon; and Tony L. White.
In welcoming Schapiro to the corporate board, Chairman
David W. Dorman commented on the
unique expertise she would bring to CVS Health.
"We welcome Mary's extraordinary record of leadership and
unmatched commitment to investor protection and sound financial
policy," said David W. Dorman,
Chairman of the Board, CVS Health. "Her extensive knowledge of the
U.S. financial and regulatory landscape and understanding of
corporate governance and complex financial infrastructure will be
of great value to the board and benefit to CVS Health and its
stockholders."
Schapiro currently serves as the Vice Chair of Promontory
Advisory Board, part of Promontory Financial Group, a leading
strategy, risk management and regulatory compliance firm that was
acquired by IBM Corporation in November
2016.
From January 2009 through
December 2012, Ms. Schapiro was
Chairman of the U.S. Securities and Exchange Commission, becoming
the first woman to serve as that agency's Chairman. During her four
years leading the agency which followed the 2008 financial crisis,
the SEC pursued one of the busiest rulemaking agendas in its
history. Additionally, the agency executed a comprehensive
restructuring program to improve protections for investors.
Before becoming SEC chairman, Ms. Schapiro served as CEO of the
Financial Industry Regulatory Authority, the largest
nongovernmental regulator of securities firms. Earlier, she was
Commodity Futures Trading Commission (CFTC) chairman and a
commissioner of the SEC. She began her career at the CFTC, serving
first as a trial attorney and later as counsel and executive
assistant to the chairman.
In addition to being the first woman to serve as SEC chairman,
Ms. Schapiro is the only person to have served as chairman of both
the SEC and the CFTC.
Ms. Schapiro is also a director of General Electric Company and
the London Stock Exchange Group. A graduate of Franklin and Marshall College, she received a JD
from George Washington University.
About CVS Health
CVS Health is a pharmacy innovation
company helping people on their path to better health. Through its
nearly 9,700 retail locations, more than 1,100 walk-in medical
clinics, a leading pharmacy benefits manager with nearly 90 million
plan members, a dedicated senior pharmacy care business serving
more than one million patients per year, expanding specialty
pharmacy services, and a leading stand-alone Medicare Part D
prescription drug plan, the company enables people, businesses and
communities to manage health in more affordable and effective ways.
This unique integrated model increases access to quality care,
delivers better health outcomes and lowers overall health care
costs. Find more information about how CVS Health is shaping the
future of health at https://www.cvshealth.com.
Media Contact:
Joe
Goode, 401-770-9820
Joseph.Goode@CVSHealth.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cvs-health-stockholders-elect-former-sec-chairman-mary-l-schapiro-as-new-director-at-annual-meeting-300455224.html
SOURCE CVS Health